Loading organizations...
Loading organizations...
Develops phage therapy for drug-resistant bacterial infections.
Arrowsmith has raised $2.0M across 1 funding round.
Arrowsmith has raised $2.0M in total across 1 funding round.
Arrowsmith has raised $2.0M in total across 1 funding round.
Arrowsmith's investors include Taira Kobayashi, JIC Venture Growth Investments.
Arrowsmith has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Pre-Series A in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 26, 2025 | $2.0M Pre-Series A | Taira Kobayashi, JIC Venture Growth Investments |